Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Bone metastasis

  • You have access
    Ibrutinib Inhibits Tumor Progression, Alleviates Pain, and Protects the Tibia in a Bone Metastasis Model of Lung Cancer
    RONG-GUANG LUO, XIAN-BING XIE, YUAN-YUAN ZHANG, YUAN-QIAO HE and QUN TANG
    Anticancer Research December 2025, 45 (12) 5477-5490; DOI: https://doi.org/10.21873/anticanres.17883
  • Open Access
    Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases
    GAKU YAMAMICHI, TAIGO KATO, AKIHIRO YOSHIMURA, MASARU TANI, YUKI HORIBE, YUTONG LIU, NESRINE SASSI, YOHEI OKUDA, TOSHIKI OKA, TOSHIHIRO UEMURA, AKINARU YAMAMOTO, YU ISHIZUYA, TAKUJI HAYASHI, YOSHIYUKI YAMAMOTO, KOJI HATANO, ATSUNARI KAWASHIMA, TETSUYA TAKAO, KENSAKU NISHIMURA, SHINGO TAKADA, MASAO TSUJIHATA and NORIO NONOMURA
    Anticancer Research February 2025, 45 (2) 639-650; DOI: https://doi.org/10.21873/anticanres.17451
  • You have access
    Serum Inflammatory Dynamics as Novel Biomarkers for Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer With Bone Metastases
    YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SATOSHI KATO, SHINJI MIWA, MIHO OKUDA, ISAO MATSUMOTO, SEIJI YANO and SATORU DEMURA
    Anticancer Research October 2024, 44 (10) 4493-4503; DOI: https://doi.org/10.21873/anticanres.17278
  • You have access
    Effect of Acridine Orange and Zoledronic Acid on Bone Metastasis in Renal Cell Carcinoma
    KEITA OYA, HIROYUKI TSUCHIE, HIROYUKI NAGASAWA, MICHIO HONGO, YUJI KASUKAWA, DAISUKE KUDO, RYO SHOJI, FUMIHITO KASAMA, TAKASHI KAWARAGI, MANABU WATANABE, KENTA TOMINAGA and NAOHISA MIYAKOSHI
    Anticancer Research June 2024, 44 (6) 2487-2495; DOI: https://doi.org/10.21873/anticanres.17055
  • You have access
    Gastric and Bone Metastases Arising from Invasive Lobular Carcinoma With Ductal Carcinoma Occurring in one Breast Synchronously
    TSUTOMU NAMIKAWA, KEIICHIRO YOKOTA, HIROMICHI MAEDA, HIROYUKI KITAGAWA, MASAYA TAMURA, HIRONAGA SATAKE, TAKEKI SUGIMOTO, MICHIYA KOBAYASHI, KAZUHIRO HANAZAKI and SATORU SEO
    Anticancer Research August 2023, 43 (8) 3701-3707; DOI: https://doi.org/10.21873/anticanres.16553
  • You have access
    Time to Pain Relapse After Palliative Radiotherapy for Bone Metastasis: A Prospective Multi-institutional Study
    ANNEYUKO I. SAITO, TAKAHISA HIRAI, TATSUYA INOUE, NOBORU HOJO, SATORU KAWAI, YUI KATO, KANA ITO, MASAKO KATO, YUKIKO OZAWA, HIDENORI SHINJO, KAZUMA TODA and RYO-ICHI YOSHIMURA
    Anticancer Research February 2023, 43 (2) 865-873; DOI: https://doi.org/10.21873/anticanres.16229
  • Open Access
    Diagnosing and Prognosing Bone Metastasis in Prostate Cancer: Clinical Utility of Blood Biomarkers
    GAKU YAMAMICHI, TAIGO KATO, MOTOHIDE UEMURA and NORIO NONOMURA
    Anticancer Research January 2023, 43 (1) 283-290; DOI: https://doi.org/10.21873/anticanres.16161
  • You have access
    Complete Response of Bone Metastasis in Non-small Cell Lung Cancer With Pembrolizumab: Two Case Reports
    YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, HIROTAKA YONEZAWA, YOSHIHIRO ARAKI, SEI MORINAGA, KAZUO KASAHARA, TAKASHI SONE and HIROYUKI TSUCHIYA
    Anticancer Research March 2021, 41 (3) 1693-1699; DOI: https://doi.org/10.21873/anticanres.14933
  • You have access
    Single-centre Experience of Use of Radium 223 with Clinical Outcomes Based on Number of Cycles and Bone Marrow Toxicity
    SEEMA DADHANIA, ROBERTO ALONZI, SUZANNE DOUGLAS, ANDREW GOGBASHIAN, ROB HUGHES, DANOOB DALILI, NIKHIL VASDEV, JIM ADSHEAD, TIM LANE, CHARLOTTE WESTBURY, NICOLA ANYAMENE, PETE OSTLER, PETER HOSKIN and ANAND SHARMA
    Anticancer Research September 2018, 38 (9) 5423-5427; DOI: https://doi.org/10.21873/anticanres.12873
  • You have access
    A Genitourinary Cancer-specific Scoring System for the Prediction of Survival in Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma
    TAKUYA OWARI, MAKITO MIYAKE, YASUSHI NAKAI, YOSUKE MORIZAWA, SHUNTA HORI, SATOSHI ANAI, NOBUMICHI TANAKA and KIYOHIDE FUJIMOTO
    Anticancer Research May 2018, 38 (5) 3097-3103;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire